Bioceres Crop Solutions Corp. (NASDAQ:BIOX) Receives Consensus Recommendation of “Buy” from Analysts

Shares of Bioceres Crop Solutions Corp. (NASDAQ:BIOX) have earned an average rating of “Buy” from the six analysts that are currently covering the firm, Marketbeat Ratings reports. Four equities research analysts have rated the stock with a buy recommendation and two have given a strong buy recommendation to the company. The average 12 month price objective among brokers that have issued ratings on the stock in the last year is $9.88.

Several brokerages recently issued reports on BIOX. Lake Street Capital reduced their price objective on Bioceres Crop Solutions from $13.00 to $8.00 and set a “buy” rating for the company in a research note on Friday, February 7th. Oppenheimer cut their price target on Bioceres Crop Solutions from $13.00 to $12.00 and set an “outperform” rating for the company in a research note on Tuesday, January 28th. Finally, Canaccord Genuity Group cut their price target on Bioceres Crop Solutions from $7.00 to $6.50 and set a “buy” rating for the company in a research note on Thursday, February 13th.

Institutional Inflows and Outflows

A number of institutional investors have recently made changes to their positions in the stock. Fourth Sail Capital LP raised its stake in shares of Bioceres Crop Solutions by 16.6% in the 4th quarter. Fourth Sail Capital LP now owns 3,698,961 shares of the company’s stock valued at $22,490,000 after acquiring an additional 527,859 shares in the last quarter. MIRAE ASSET GLOBAL ETFS HOLDINGS Ltd. raised its stake in shares of Bioceres Crop Solutions by 135.0% in the 4th quarter. MIRAE ASSET GLOBAL ETFS HOLDINGS Ltd. now owns 752,335 shares of the company’s stock valued at $4,574,000 after acquiring an additional 432,206 shares in the last quarter. Long Focus Capital Management LLC raised its stake in shares of Bioceres Crop Solutions by 130.7% in the 4th quarter. Long Focus Capital Management LLC now owns 744,748 shares of the company’s stock valued at $4,528,000 after acquiring an additional 421,931 shares in the last quarter. Ballast Asset Management LP raised its stake in shares of Bioceres Crop Solutions by 23.5% in the 4th quarter. Ballast Asset Management LP now owns 431,887 shares of the company’s stock valued at $2,620,000 after acquiring an additional 82,187 shares in the last quarter. Finally, JPMorgan Chase & Co. raised its stake in shares of Bioceres Crop Solutions by 17.0% in the 4th quarter. JPMorgan Chase & Co. now owns 105,301 shares of the company’s stock valued at $640,000 after acquiring an additional 15,328 shares in the last quarter. 17.68% of the stock is owned by institutional investors.

Bioceres Crop Solutions Stock Up 2.2 %

Shares of Bioceres Crop Solutions stock opened at $5.22 on Wednesday. The stock has a 50-day moving average price of $5.83 and a 200 day moving average price of $6.91. The company has a market cap of $327.35 million, a P/E ratio of 261.13 and a beta of 0.73. The company has a current ratio of 1.33, a quick ratio of 0.96 and a debt-to-equity ratio of 0.43. Bioceres Crop Solutions has a 1 year low of $3.69 and a 1 year high of $13.18.

About Bioceres Crop Solutions

Bioceres Crop Solutions Corp., together with its subsidiaries, provides crop productivity solutions. It operates through Seed and Integrated Products, Crop Protection, and Crop Nutrition segments. The Seed and Integrated Products segment provides seed traits, germplasms, and seed treatment packs for healthier, and higher yielding crops.